Table 1 Baseline characteristics between influenza A induced ARDS and COVID-19-induced ARDS.
Characteristics | Total participants (N = 87) | Influenza A induced ARDS (N = 45) | COVID-19-induced ARDS (N = 42) | p-value |
|---|---|---|---|---|
Age (year) | 71.0 (62.0–78.0) | 73.0 (62.5–79.5) | 69.5 (62.0–76.0) | 0.322 |
Male, no. (%) | 55 (63.2) | 29 (64.4) | 26 (61.9) | 0.806 |
Smoking status (Current or former), no. (%) | 25 (28.7) | 14 (31.1) | 11 (26.2) | 0.612 |
BMI (kg/m2) | 22.8 (19.9–25.1) | 20.3 (17.7–24.1) | 24.3 (22.2–25.9) | < 0.001 |
CCI | 1.0 (0.0–4.0) | 3.0 (1.0–5.0) | 1.0 (0.0–1.3) | < 0.001 |
SOFA | 9.0 (5.0–13.0) | 11.0 (7.5–14.5) | 6.5 (4.0–11.0) | < 0.001 |
Use of vasopressor, no (%) | 71 (81.6) | 42 (93.3) | 29 (69.0) | 0.005 |
RRT, no (%) | 13 (14.9) | 12 (26.7) | 1 (2.4) | 0.002 |
ICU hospitalization period (day) | 20.0 (9.0–32.0) | 10.0 (7.0–23.5) | 24.5 (19.0–51.5) | < 0.001 |
28-day mortality, no (%) | 20 (23.0) | 16 (35.6) | 4 (9.5) | 0.005 |
Final mortality, no (%) | 32 (36.8) | 22 (48.9) | 10 (23.8) | 0.015 |
Tracheostomy, no (%) | 20 (23.0) | 8 (17.8) | 12 (28.6) | 0.232 |
Weaning success, no (%) | 49 (56.3) | 25 (55.6) | 24 (57.1) | 0.881 |